Previwo

Probiotic products for farmed salmon and trout that strengthen fish health in aquaculture

Oslo, NorwayFounded 2013previwo.comWebsite technologies

+ Add to sales board

Highlights

  • New on EvolcAdded 2026-10-30

About Previwo

Previwo develops probiotics for farmed fish. Its product Stembiont® Vital is a probiotic for farmed salmon and trout, made of naturally occurring bacteria introduced to fish during the smolt stage.

Its customers are fish farms and aquaculture operators in the Nordic region. Partnerships include a three-year agreement with Andfjord Salmon and a partnership with veterinary services in Iceland. The company is built on a method for identifying and selecting specific probiotic bacterial strains.

Previwo is a Norwegian biotechnology company based in Oslo, founded in 2013. It originates from research by Professor Henning Sørum at the Norwegian University of Life Sciences (NMBU). A new research lab for probiotics was announced in March 2026.

Product: Stembiont® Vital, a probiotic for farmed salmon and trout

Jobs at Previwo

No open positions listed right now.

More biotech & pharma companies

  • Prophylaxia

    Researches salmon signalling substances such as SNAP as a sea lice alternative for salmon farming
    Vikebukt, NorwayBiotech & pharmaFounded 2009
    New on Evolc
  • Quantidoc

    Immune barrier health monitoring for fish farms and hatcheries using its VERIBARR™ analyses of gills, skin and gut
    Bergen, NorwayBiotech & pharmaFounded 2013
    New on Evolc
  • Regenics

    Develops marine-derived wound care products for treating burns and chronic wounds
    Oslo, NorwayBiotech & pharmaFounded 2000
    New on Evolc
  • Seannovation

    Tailor-made polymer products derived from brown seaweed
    Sandefjord, NorwayBiotech & pharmaFounded 2023
    Young companyNew on Evolc
  • Thor Medical

    Produces thorium-derived alpha-particle emitters for makers of radioligand cancer therapies and research users
    Oslo, NorwayBiotech & pharmaFounded 2009
    New on Evolc
  • Tribune Therapeutics

    Preclinical biopharma developing anti-fibrotic medicines that target CCN signaling, for patients with fibrotic disease
    Oslo, NorwayBiotech & pharmaFounded 2021
    New on Evolc

All biotech & pharma companies →

Website technologies

Older, unverified list. Detection dates and supporting evidence are not yet available.

  • Next.js
  • React
  • Sanity
  • Tailwind CSS
  • Vercel